Call THERA Patient Support®
1-833-23THERA (1-833-238-4372)
Mon-Fri 8:30 a.m. – 8 p.m. EST
The daily 1.4 mg dose of EGRIFTA SV® is reconstituted from a vial containing 2 mg of tesamorelin as a lyophilized powder
Once reconstituted, EGRIFTA SV® should be administered immediately
Fill syringe with sterile water to 0.5 mL line